Lidocaine Hydrochloride And Epinephrine Injection, Solution
Product Images NDC 0404-9891

12 FDA label images from Henry Schein, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride And Epinephrine (NDC 0404-9891). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image1.jpg (Image1)

Image1.jpg (Image1)
A data table listing concentrations of Lidocaine Hydrochloride and Epinephrine along with corresponding levels of Lidocaine HCl (anhydrous), Epinephrine, and Sodium Chloride in mg/mL or mcg/mL. The table shows various dilution ratios and their associated component strengths.*
FDA Label Image

Image2.jpg (Image2)

Image2.jpg (Image2)
This text panel provides information about specific available products of Lidocaine Hydrochloride and Epinephrine Injection, USP, recommended by Hospira for epidural anesthesia. It lists various concentrations and corresponding single-dose vial sizes, including 1% and 1.5% solutions with epinephrine 1:200,000 in 30 mL vials, and 2% solution with epinephrine 1:200,000 in 20 mL vials, as well as 1.5% with epinephrine 1:200,000 in 5 mL single-dose ampuls.*
FDA Label Image

Image3.jpg (Image3)

Image3.jpg (Image3)
A table titled "Recommended Dosages Lidocaine Hydrochloride Injection, USP (without Epinephrine)" listing concentrations, volume in mL, and total dose in mg for various procedures. It includes infiltration, peripheral nerve blocks, sympathetic nerve blocks, and central neural blocks, with specific dose ranges for each procedure and notes that doses are guidelines and maximum dose should not be exceeded.*
FDA Label Image

Image4.jpg (Image4)

Image4.jpg (Image4)
Table titled "Recommended Dosages" presenting dose concentration, volume, and total dose for Lidocaine Hydrochloride Injection USP (without Epinephrine). It outlines recommended dosages by procedure type including infiltration, peripheral nerve blocks, sympathetic nerve blocks, and central neural blocks, with specific values for concentration percentage, volume in milliliters, and total dose in milligrams.*
FDA Label Image

Formula1.jpg (Formula1)

Formula1.jpg (Formula1)
Chemical structure diagram showing the molecular formula of Lidocaine Hydrochloride, including its chemical groups and composition as hydrochloride and hydrate form.*
FDA Label Image

Formula2.jpg (Formula2)

Formula2.jpg (Formula2)
Chemical structure diagram of the active ingredient Lidocaine Hydrochloride and Epinephrine, showing its molecular arrangement with phenol groups, hydroxyl groups, and amine substitutions.*
FDA Label Image

Image5.jpg (Image5)

Image5.jpg (Image5)
A data table listing units of sale and concentration for Lidocaine Hydrochloride injection. It shows 1.5% solution containing 15 mg/mL lidocaine hydrochloride. Pack sizes include trays of 10 single-dose ampuls, cases of 400, and cases of 800 single-dose ampuls, all at 75 mg/5 mL (15 mg/mL). Corresponding NDC codes are provided for each pack size.*
FDA Label Image

Image6.jpg (Image6)

Image6.jpg (Image6)
A data table showing unit of sale and concentration for lidocaine hydrochloride injection products. It lists a 1.5% concentration with 15 mg/mL in cartons of five single-dose fliptops (NDC 0409-3181-01, 450 mg/30 mL total), and a 2% concentration with 20 mg/mL in cartons of five single-dose fliptops (NDC 0409-3183-01, 400 mg/20 mL total).*
FDA Label Image

Image7.jpg (Image7)

Image7.jpg (Image7)
A data table detailing unit of sale and concentration information for lidocaine hydrochloride. It lists '0.5% Contains 5 mg lidocaine hydrochloride per mL' and a product with NDC 0409-3177-01, packaged as a tray of 25 multiple-dose fliptop vials, with concentration 250 mg/50 mL (5 mg/mL).*
FDA Label Image

Image8.jpg (Image8)

Image8.jpg (Image8)
Data table listing units of sale and concentration for Lidocaine Hydrochloride injection solutions. It details multiple packaging options such as cartons and trays of multiple-dose flit top vials, with concentrations of 1% (10 mg/mL) and 2% (20 mg/mL), including amounts ranging from 200 mg to 1000 mg in various volume sizes.*
FDA Label Image

Label1.jpg (Label1)

Label1.jpg (Label1)
Label of Lidocaine Hydrochloride 1% and Epinephrine 1:100,000 Injection, USP, 30 mL multiple-dose vial. The label includes storage instructions, warnings against autoclaving, and advises to avoid use if discoloration or precipitate is present. It is packaged by Henry Schein, Inc., located in Bastian, VA, with an NDC of 0404-9891-20.*
FDA Label Image

Label2.jpg (Label2)

Label2.jpg (Label2)
Label for Lidocaine Hydrochloride 1% and Epinephrine 1:100,000 injection, US Pharmacopeia (USP) Multiple Dose, 20 mL vial. The label includes storage instructions to protect from light, avoid autoclaving, and keep at controlled room temperature. It states the product is for infiltration and nerve block only, not for epidural or caudal use. Packaged by Henry Schein, Inc., Bastian, VA, with an NDC barcode visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.